Article and Video CATEGORIES

Cancer Journey

Search By

Alexandra was born in El Salvador and has always had a very strong desire to do something that allows her to help others. She has worked in Digital Marketing since 2015, gaining experience working with different clients throughout Central America and the US.

She has been involved with cancer very closely in her family and knows that there’s never enough we can do to help cancer patients and families go through this difficult path.

2024 Ovarian Cancer Patient Education Program
AlexandraGBeneke
Oncologists discuss emerging information and leading treatment techniques for patients with ovarian cancer.
Author
Alexandra Guandique-Beneke
Image
Ovarian Cancer 2024

In these videos, Dr. Mansoor Mirza discusses how endometrial cancer treatment has changed in the past decade, adjuvant radiotherapy for patients with early-stage disease, current phase III trials of adjuvant radiotherapy with chemo, and adjuvant chemo alone, the molecular profile of endometrial cancers and how it pertains to immunotherapy, immunotherapy options for treating advanced or recurrent endometrial cancer, study results from first-line endometrial cancer studies, and key takeaways to point out when discussing the changing field of endometrial cancer treatment.

To watch the complete playlist, click here. 

Transcripts.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

A Brief Tornado.  I love the analogy Dr. Antonoff gave us to describe her presentation.  I felt it earlier too and am looking forward to going back for deeper dive.

Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".

While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".  

I hope any...

My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.

Here's the webinar on YouTube.  It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

Recent Comments

JOIN THE CONVERSATION
Webinar OnDemand
By JanineT GRACE … on
My understanding of ADCs is…
By JanineT GRACE … on
Right patient, right time,…
By JanineT GRACE … on
A Brief Tornado.  I love the…
By JanineT GRACE … on